Login / Signup

Efficacy and safety of neuronox® for lateral canthal lines: a phase I/III, multicenter, randomized, double-blind, active-controlled study.

Young-Kyoung LimJong Hee LeeWoo Shun LeeWeon Ju LeeYoon-Seob KimMin-Kyung ShinSik HawChang Hun Huh
Published in: The Journal of dermatological treatment (2019)
Treatment of moderate to severe LCL with Neuronox® was effective and well-tolerated.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii
  • open label
  • study protocol
  • minimally invasive
  • early onset
  • randomized controlled trial
  • combination therapy
  • cross sectional